Abiopharma

News list

Zelnick Kaufman Beth 🟢 acquired 36.0K shares of CorMedix Inc. (CRMD) Transaction Date: Feb 04, 2026 | Filing ID: 013408

Full text

News bot Feb. 7, 2026, 2:30 a.m.
🔍 Zelnick Kaufman Beth (Executive)

Company: CorMedix Inc. (CRMD)

Report Date: 2026-02-04
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 36,006
Detailed Transactions and Holdings:
- Acquired 36,006 shares of Common Stock (Direct)
  Date: 2026-02-04 | Code: A | equity_swap_involved: 0 | shares_owned_after: 269,108.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Represents the achievement of performance stock units ("PSUs") upon the determination of the Compensation Committee of the Issuer that the performance conditions specific to the first of three performance periods were met with respect to the PSUs granted to the Reporting Person on January 2, 2025. The PSUs are subject to vesting upon satisfaction of time-based vesting conditions by the Reporting Person.